Beyond the sum of its parts: reassessing cardiovascular screening through the full DANCAVAS lens

Q: What does this research mean for the field?

Cardiovascular screening programs should be evaluated comprehensively across their multi-component interventions and collective long-term outcomes rather than assessed solely by individual parts. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

doi:10.1093/eurheartj/ehaf848

November 13, 2025European Heart Journal

Beyond the sum of its parts: reassessing cardiovascular screening through the full DANCAVAS lens

View Full Paper

Ask AI

Bookmark

Share

Key Points

Key points are not available for this paper at this time.

Design

Editorial

Implication

This is an editorial discussing the DANCAVAS II trial on cardiovascular screening in men aged 60-64 years.

Abstract

This editorial refers to ‘Outcomes of cardiovascular screening in men aged 60–64 years: the DANCAVAS II trial’, by J.S. Lindholt et al., https://doi.org/10

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

A 2025 study studied this question.

synapsesocial.com/papers/6a86b6083d239a2773cf7b2d https://doi.org/10.1093/eurheartj/ehaf848

View Full Paper

Ask AI

Bookmark

Share

Beyond the sum of its parts: reassessing cardiovascular screening through the full DANCAVAS lens

Key Points

Implication

Abstract

Discussion

Cite This Study

Beyond the sum of its parts: reassessing cardiovascular screening through the full DANCAVAS lens

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading